AstraZeneca diabetes drug approved for treating heart failure risk

AstraZeneca's diabetes drug Farxiga has been approved to be used within USA as a treatment to cut back the probabilities of medical aid for a heart condition in adults with type-2 diabetes and alternative vessel risks, British drug maker same on Mon.

The approval by the U.S. Food and Drug Administration is predicated on results from the DECLARE-TIMI 58 trial, the London-listed company same, and follows an analogous approval here ....